Top shareholders of TBPH - Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Institutional Holders of Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) as of Q2 2014
As of 30 Jun 2014,
Theravance Biopharma, Inc. - Ordinary Share $0.00001 Par Value (TBPH) was held by
89 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,300,819 shares.
The largest 10 holders included
BAUPOST GROUP LLC/MA, IRIDIAN ASSET MANAGEMENT LLC/CT, VANGUARD GROUP INC, OPPENHEIMER FUNDS INC, BlackRock Fund Advisors, CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD, BlackRock Institutional Trust Company, N.A., State Street Corp, FMR LLC, and EAGLE ASSET MANAGEMENT INC.
This page lists
89
institutional shareholders reporting positions in this security
for the Q2 2014 filing period.
Investor
Option
Weight %
Change %
Value $
* Price
Shares
Share Change
Activity
Report Period
Compare Q2 2014 vs Q1 2014 Across Filers
Q1 2014 holders
1
Q2 2014 holders
89
Holder diff
88
Investor
Q1 2014 Shares
Q2 2014 Shares
Share Diff
Share Chg %
Q1 2014 Value $
Q2 2014 Value $
Value Diff $
Value Chg %
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and, if you allow them, measure engagement and deliver
advertising. Analytics and marketing storage stay off until you grant
consent. By clicking on "Agree and continue", you declare your consent to
the use of the selected optional cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.